Trial Summary
What is the purpose of this trial?The investigators propose a Type I hybrid effectiveness/implementation study to evaluate two population-based approaches for increasing use of Quitlines and text messaging at two VA sites. Specifically, the investigators will test the default bias, examining whether an opt-out approach to referral is more effective than an opt-in approach. The investigators will randomly assign teams to either an opt-out or opt-in approach to referring smokers to treatment. In the opt-out approach, the default is that everyone is referred to treatment unless they actively choose not to be. In the opt-in approach, people are offered treatment but must actively choose to enroll in it.
Eligibility Criteria
This trial is for current smokers who have been seen by a nursing assistant on the PACT team at the Manhattan or Brooklyn VA campus within the last year. It's also open to those nurses and administrative staff who smoke. Non-English speakers cannot participate.Treatment Details
The study is comparing two methods of encouraging smoking cessation: an 'opt-out' where smokers are automatically referred to treatment unless they decline, and an 'opt-in' where smokers must actively choose to enroll in treatment programs.
2Treatment groups
Experimental Treatment
Group I: Opt-out tobacco treatmentExperimental Treatment1 Intervention
The investigators will directly change the treatment status quo by implementing a clinical reminder that automatically initiates tobacco treatment referral at the time the reminder is activated.
Group II: Opt-in clinical reminderExperimental Treatment1 Intervention
As the investigators have done previously, the reminder will be self-explanatory, and will walk staff through each step of referral. The reminder will include the following domains: normative advice, referral to treatment, handout
Find a clinic near you
Research locations nearbySelect from list below to view details:
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NYNew York, NY
Loading ...
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor